A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model

PURPOSE: In advanced gastric cancer, peritoneal dissemination is a life‐threatening mode of metastasis. Since the treatment options with conventional chemotherapy remain limited, any novel therapeutic strategy that could control such metastasis would improve the outcome of treatment. We recently dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Hidenori, Fukushima, Masakazu, Eshima, Kiyoshi, Hasui, Taichi, Shimizu, Taro, Ishima, Yu, Huang, Cheng‐Long, Wada, Hiromi, Ishida, Tatsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885878/
https://www.ncbi.nlm.nih.gov/pubmed/31609087
http://dx.doi.org/10.1002/cam4.2598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885878/
https://www.ncbi.nlm.nih.gov/pubmed/31609087
http://dx.doi.org/10.1002/cam4.2598

Ejemplares similares